{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "currency": "HKD", "market": "hk_market", "esgPopulated": false, "gmtOffSetMilliseconds": 28800000, "exchange": "HKG", "longName": "Hua Medicine (Shanghai) Ltd.", "shortName": "HUA MEDICINE-B", "regularMarketPrice": 2.76, "regularMarketChangePercent": 0.7299263, "messageBoardId": "finmb_114980744", "marketState": "CLOSED", "fiftyTwoWeekHighChangePercent": -0.45019922, "fiftyTwoWeekLow": 1.85, "fiftyTwoWeekHigh": 5.02, "earningsTimestamp": 1680142500, "earningsTimestampStart": 1680142500, "earningsTimestampEnd": 1680142500, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.90999997, "fiftyTwoWeekLowChangePercent": 0.49189186, "fiftyTwoWeekRange": "1.85 - 5.02", "fiftyTwoWeekHighChange": -2.26, "epsTrailingTwelveMonths": -0.22, "epsForward": 0.07, "epsCurrentYear": -0.26, "priceEpsCurrentYear": -10.615385, "sharesOutstanding": 970110976, "bookValue": 0.287, "fiftyDayAverage": 3.4074, "fiftyDayAverageChange": -0.6473999, "fiftyDayAverageChangePercent": -0.18999821, "twoHundredDayAverage": 3.6163, "twoHundredDayAverageChange": -0.8563001, "twoHundredDayAverageChangePercent": -0.236789, "marketCap": 2677506304, "forwardPE": 39.42857, "priceToBook": 9.616725, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1536888600000, "priceHint": 3, "regularMarketChange": 0.01999998, "regularMarketTime": 1683878916, "regularMarketDayHigh": 2.77, "regularMarketDayRange": "2.7 - 2.77", "regularMarketDayLow": 2.7, "regularMarketVolume": 342000, "regularMarketPreviousClose": 2.74, "bid": 2.74, "ask": 2.78, "bidSize": 0, "askSize": 0, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 2.72, "averageDailyVolume3Month": 1403692, "averageDailyVolume10Day": 1074650, "symbol": "2552.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building A", "address2": "Room 2005 20 Middle East Third Road Chaoyang District", "city": "Beijing", "country": "China", "website": "https://www.huamedicine.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with insulin for late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease; and Fructokinase Inhibitor for Metabolic disease. The company was incorporated in 2011 and is based in Beijing, China.", "fullTimeEmployees": 144, "companyOfficers": [{"maxAge": 1, "name": "Dr. Li  Chen Ph.D.", "age": 59, "title": "Founder, CEO & Exec. Director", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 1622627, "fmt": "1.62M", "longFmt": "1,622,627"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Chien Cheng  Lin J.D.", "age": 50, "title": "Exec. VP, Chief Strategy Officer & Exec. Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 836482, "fmt": "836.48k", "longFmt": "836,482"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Di  Hong", "age": 43, "title": "VP of Operation Department", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Emily  Yeh", "title": "Director of Corp. Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Fuxing  Tang Ph.D.", "age": 55, "title": "CTO, VP of Chemical Manufacturing Control Department and Head of R&D in USA", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Changhong  Li Ph.D.", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Chengde  Wang", "age": 74, "title": "Head of IR", "yearBorn": 1948, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Wenjie  Xu M.B.A.", "age": 50, "title": "VP and Head of Commercial Strategy & Marketing", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yi  Zhang M.D., Ph.D.", "age": 47, "title": "Sr. VP of Pharma Devel. & Chief Medical Officer \u0096 China", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jin  She Ph.D.", "age": 49, "title": "Sr. VP of Chemical Manufacturing Control Department & Chief Manufacturing Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}